These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19133165)

  • 1. Peri-operative medical management of cerebral vasospasm.
    Deshaies EM; Boulos AS; Popp AJ
    Neurol Res; 2009 Jul; 31(6):644-50. PubMed ID: 19133165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm.
    Ehtisham A; Taylor S; Bayless L; Samuels OB; Klein MW; Janzen JM
    South Med J; 2009 Feb; 102(2):150-3. PubMed ID: 19139684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based pharmacotherapy for cerebral vasospasm.
    Deshaies EM; Boulos AS; Drazin D; Popp AJ
    Neurol Res; 2009 Jul; 31(6):615-20. PubMed ID: 19108757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in vasospasm treatment and prevention.
    Komotar RJ; Zacharia BE; Valhora R; Mocco J; Connolly ES
    J Neurol Sci; 2007 Oct; 261(1-2):134-42. PubMed ID: 17570400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
    Wu CT; Wong CS; Yeh CC; Borel CO
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage.
    Keyrouz SG; Diringer MN
    Crit Care; 2007; 11(4):220. PubMed ID: 17705883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-operative measures for treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage.
    Alaraj A; Charbel FT; Amin-Hanjani S
    Neurol Res; 2009 Jul; 31(6):651-9. PubMed ID: 19133166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage.
    Weant KA; Ramsey CN; Cook AM
    Pharmacotherapy; 2010 Apr; 30(4):405-17. PubMed ID: 20334460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical care guidelines on the endovascular management of cerebral vasospasm.
    Kimball MM; Velat GJ; Hoh BL;
    Neurocrit Care; 2011 Sep; 15(2):336-41. PubMed ID: 21761272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endovascular treatment of cerebral vasospasm due to aneurysmal subarachnoid hemorrhage].
    Alcázar PP; González A; Romance A
    Med Intensiva; 2008 Nov; 32(8):391-7. PubMed ID: 19055932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary management of subarachnoid hemorrhage and vasospasm: the UIC experience.
    Corsten L; Raja A; Guppy K; Roitberg B; Misra M; Alp MS; Charbel F; Debrun G; Ausman J
    Surg Neurol; 2001 Sep; 56(3):140-8; discussion 148-50. PubMed ID: 11597631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice.
    Velly LJ; Bilotta F; Fàbregas N; Soehle M; Bruder NJ; Nathanson MH;
    Eur J Anaesthesiol; 2015 Mar; 32(3):168-76. PubMed ID: 25303971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular options in the treatment of delayed ischemic neurological deficits due to cerebral vasospasm.
    Eddleman CS; Hurley MC; Naidech AM; Batjer HH; Bendok BR
    Neurosurg Focus; 2009; 26(3):E6. PubMed ID: 19249962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational drugs for vasospasm after subarachnoid hemorrhage.
    Tallarico RT; Pizzi MA; Freeman WD
    Expert Opin Investig Drugs; 2018 Apr; 27(4):313-324. PubMed ID: 29600883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone.
    Schmidt U; Bittner E; Pivi S; Marota JJ
    Anesth Analg; 2010 Mar; 110(3):895-902. PubMed ID: 20185665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion.
    Doukas A; Petridis AK; Barth H; Jansen O; Maslehaty H; Mehdorn HM
    Acta Neurochir Suppl; 2011; 112():93-6. PubMed ID: 21691994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
    Liu-Deryke X; Rhoney DH
    Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.